Introduction: In advanced stages of ankle osteoarthritis (OA), ankle arthrodesis (AA) or total ankle arthroplasty (TAR) may be necessary. Our purpose is to compare AA and total ankle replacement for the surgical management of end stage ankle OA.
Introduction
Degenerative conditions of the ankle joint, from traumatic injuries or metabolic factors, are a growing problem. [1] [2] [3] Approximately 1% of the world's adult population presents ankle osteoarthritis (OA). 4, 5 Ankle OA is associated with pain, dysfunction and impaired mobility, at least as severe as those associated with hip OA. 5 In contrast to OA of the knee or hip, ankle OA is usually primary or posttraumatic, but rheumatic diseases, gout, hemochromatosis, avascular necrosis, hemophilia and postinfectious states also play a role. 4, [6] [7] [8] [9] In the early stages, conservative management may decrease pain and, potentially, preserve function. 10 However, in advanced stages, ankle arthrodesis (AA) or total ankle arthroplasty (TAR) may be necessary. 11 AA has been the gold standard treatment in patients with end stage ankle OA, until the 1970s, when the first TAR procedures were described. [12] [13] [14] [15] [16] [17] [18] [19] [20] Many surgeons still consider AA as the procedure of choice to alleviate pain in patients with end stage ankle OA, but, as a result of ankle joint motion limitation, gait efficiency is decreased. [21] [22] [23] Furthermore, a number of studies have revealed an increase in several complications, such as nonunion, malalignment, infection and development of OA in the neighboring joints. [24] [25] [26] The results of the first generation of TAR were disappointing, with poor clinical results and high rates of prosthetic loosening. [27] [28] [29] [30] For decades, surgeons have explored arthroplasty procedures that have proven effective in other large joints. These results have led researchers to search for designs which more closely replicate the natural anatomy of the ankle. 17, [31] [32] [33] [34] [35] Currently, even though controversy still exists about the effectiveness of TAR compared to ankle fusion, TAR has shown promising results and should be considered a treatment option for ankle OA. 36 TAR could preserve ankle motion and preserve joint function, with little or no pain, although revision surgery for prosthetic loosening may be problematic. 37 This systematic review compares AA and TAR for the surgical management of end stage ankle OA.
Materials and methods

Search strategy
We conducted a literature search of PubMed, Medline, CINAHL, Cochrane, Embase and Google Scholar databases using the terms 'ankle' in combination with 'OA', 'arthrodesis', 'arthroplasty', 'joint fusion', 'joint replacement' over the years . Eligibility criteria are summarized in Table 1 . Review articles were excluded, and articles were limited to human studies published in English. All articles relevant to the subject were retrieved, and their bibliographies hand searched for further references in this context. Reviewers (U.G.L., G.R. and J.L.), scanned the bibliographies of all retrieved studies and other relevant publications, including reviews and meta-analyses, for additional relevant articles. We excluded case reports, case series and letters to editors. To satisfy inclusion criteria, all potentially eligible studies had to report on patients with end stage ankle arthritis, managed by arthrodesis (joint fusion) or TAR. Studies where treatment was exclusively TAR or AA were excluded. Each study was examined to extract data on characteristics of patients, length of follow-up, surgical procedures, post-operative assessment and patients' satisfaction (when available, although validated outcomes were not often reported). The overall complication rate for both procedures (poor alignment/non-union, infections, fractures and technical error) and number of revisions have also been described. Only articles published in peer-reviewed journals were included in this systematic review.
Quality assessment
To assess the quality of the included studies, we used the Coleman Methodology Score (CMS), which assesses methodology with use of ten criteria, giving a total score ranging between 100 and 0 points. A score of 100 indicates that the study largely avoids confounding factors, chance and various biases. The final score will be defined as excellent (85-100 points), good (70-84 points), fair (50-69 points) or poor (<50 points). The subsections that make up the CMS are based on the subsections of the CONSORT statement (for randomized controlled trials) and are modified to allow for other trial designs. 38 We modified the Coleman criteria to make them reproducible and relevant for the systematic review of ankle prosthesis (Table 2) .
Statistical analysis
Study, patient and treatment characteristics were summarized in Table 1 . Student's t-test was used to compare the outcomes of AA and TAR groups reported in the included studies. Pearson's chi-squared test 'exact' was used to assess the safety of the two different procedures. Follow-up scores on scales evaluating ankle pain, function, quality of life, and range of motion were summarized for both TAR and AA. Studies included in this review had all high quality and level of evidence (e.g. randomized control trials, retrospective, prospective and prognostic comparative studies). Mean values highlight general trends, but cannot conclude whether statistically significant differences exist between AA and TAR. All statistical analyses were conducted with SPSS version 14.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Literature search
Of the 427 articles initially identified by the search, 21 studies 39-59 met the inclusion criteria ( Fig. 1 ).
All data were retrieved from included studies, published from January 1988 to January 2017, comparing AA and TAR procedures, with a minimum of 6 months follow-up (Table 3) . Preoperative and postoperative outcomes for each study were analyzed (Table 4) . Level of evidence (I, II and III) were reported for the included studies.
Quality assessment
The mean value of the CMS score was 42.5 points, showing that the mean quality of included study was poor. Detailed values of the Coleman score are reported in Table 1 .
Patient population
The included 21 studies reported a total of 32 422 procedures for the management of end stage ankle 
Clinical questionnaires assessment and outcome measurements
Using validated outcome scores, all studies documented the severe impact of end stage ankle arthritis on life quality and postoperative outcome. Different rating systems were used among the included studies ( Table 4 ). The most frequent rating system used among the included studies for TAR was the American Orthopaedic Foot & Ankle Surgery (AOFAS) Scale, 61 used in six studies reporting 363 procedure. 39, 40, 42, 44, 50, 53 This is a patient-reported outcome frequently used in the literature, however, the original version of the questionnaire has not been validated. The AOFAS score evaluates pain, function, hindfoot motion, and alignment, with excellent defined as 90-100 points; good, as 75-89 points; fair, as 50-74 points; and poor, as <50 points. One study, 53 using the University of California at Los Angeles (UCLA) activity scale, found no significant difference between the TAR and the AA group. The UCLA activity scale has been shown to be a feasible measure to assess preoperative and postoperative activity levels in patients with ankle OA. 62 The UCLA scale is a simple scale, ranging from 1 to 10, with level 1 defined as 'no physical activity, dependent on others' and level 10 defined as 'regular participation in impact sports'. 63 The foot function was evaluated using the Ankle Osteoarthritis Scale (AOS). 64 This is a simple, reli- Improvements in patient-reported AOS and SF-36scores were similar for both treatment groups TAR was independently associated with a lower risk of blood transfusion, non-home discharge, and overall complication when compared to AA. TAR was also associated with a higher hospitalization charge, but length of stay was similar between the two groups. There were no significant difference in risk for the majority of medical perioperative complications
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In an effort to provide a more comprehensive evaluation, data obtained from the SF-36 can also be transformed using an algorithm described by Brazier et al. 67 This transformation produces six dimensions (SF-6D), including physical functioning, role limitation, social functioning, bodily pain, mental health and vitality. 68 Summing the weighted values for each dimension derives a single health state value range from 0.30 to 1.00, with a score of 1.00 representing full health. In our review, only one study 55 used the SF-6D score.
The Buechel and Pappas (BP) system is a 100 point scale which assesses pain (40 points), function (40 points), deformity (5 points) and joint motion (15 points). 69 This score was used in one study.
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Other scores reported were the Kofoed ankle score, the foot and ankle-related Quality of Life (FAOS-QOL) and the SF-12, each used in one study 39, 46, 49 
Diagnosis
In 10 of the 21 included studies, 24, 25, 63, [70] [71] [72] [73] [74] [75] [76] describing 752 ankles, the specific diagnosis of end stage ankle OA was reported. Primary OA of the ankle was diagnosed in 258 of 752 (40%) ankles, post-traumatic arthritis in 276 (43%), and rheumatoid arthritis in 87 (13%).
In one study 77 not reporting the specific etiology of the condition, among the 5185 ankles treated, 10% of patients undergoing TAR had ankle OA secondary to rheumatoid arthritis, while these patients were 6% in the AA group; ankle OA related to diabetes was 5% in the TAR group and 9% for the AA group. In two studies, 66, 68 including 237 ankles, the diagnosis was not systematically investigated for each group.
Surgery
A total of 26 175 (80.7%) AA and 6247 (19.3%) TAR procedures were performed (Table 3) . Seven studies, [39] [40] [41] 44, 47, 49, 54 reporting 647 TAR procedures, also reported the type of prosthesis of choice. TAR was performed using two-or three-component designs. These were also classified as fixed or 45 A Forty-one Salto-Talaris fixed bearing implants (Tornier, Bloomington, Minnesota) and 32 Ankle Evolutive System (AES) (Biomet Inc., Valence, France) were also implanted 40, 49 In one study, 25 
Complications
The number of events and length of follow-up varied among the included studies (Table 3) . We excluded studies that did not present complication rates for each procedure. Reported complication included poor alignment/non-union, infections, fractures, implant loosening, subtalar arthrosis, skin necrosis, nerve injury, lateral/posterior impingement, deep venous thrombosis, osteolysis and polyethylene wear or breakage (Table 5) .
Poor alignment/non-union Five studies reported an incidence of non-union in patients treated with an AA of 13.7% (n = 17). 42, [46] [47] [48] 51 Two studies, reporting 15 patients with complications for AA, did not specify whether malalignment or nonunion took place. 41, 58 In the TAR group, one patient required revision of fixation after medial malleolar osteotomy for nonunion. 51 Also four cases of nonunion of an adjacent joint fusion (two talonavicular, one naviculocuneiform and one syndesmosis fusion) were reported in the TAR group. 47 Limb malalignments occurred in 4 (6.3%) of 63 patients in the AA group, and in 4 (3.1%) of 128 patients in the TAR group.
42,47
Infections Twenty (6.1%) first infection events were observed in patients treated with AA, 42, 46, 48, 52 ,58 compared with 37 episodes (3.4%) in patients undergoing TAR procedures.
Fractures
Tibial or peroneal fractures were reported in four studies 42, 47, 51, 52 . 3 (1.9%) of 158 patients in the AA group, and in 45 (13.7%) of 328 patients in the TAR group.
Technical error and implant failure
A technical error occurred in 112 (12.6%) of the 892 TAR, including medial or lateral gutter impingement (n = 12), polyethylene wear or breakage (n = 3) and implant loosening (n = 46) and implant failure (n = 51).
Revision rate
The revision rate for AA was 10.3% (n = 48 of 465 patients); for TAR it was 20.5% (n = 218 of 1064 patients; odds ratio 2.28 95% confidence interval [CI], 1.63-3.19; P < 0.0001) (Fig. 2) .
Return to sport
One study 63 investigated return to sports after AA or TAR. Forty-one patients were treated either by AA (20 patients) or by TAR (21 patients). The 2014 AA Malalignment or non-union,
0 0 0 Removal and revision of TAR (48); AA (7) Amputation ( authors distributed questionnaires on physical and sports activity, evaluating patient's preoperative and postoperative engagement in several different sports and recreational activities. The most common activities were cycling, swimming, hiking and skiing. There was no statistically significant difference between the AA and the TAR groups, according to the percentage of patients participating in sport either preoperatively or postoperatively. Return to recreational or sporting activities was generally possible after TAR, but impact sports or strenuous activities were rarely possible.
Discussion
This study showed that, even though TAR has become an accepted treatment for end-stage OA, the revision rate for TAR was significantly higher than the revision rate for AA (odds ratio 2.28 95% CI, 1.63-3.19; P < 0.0001). McGuire et al. reported that, in 23 patients treated with TAR, there were five failures requiring prosthesis removal. 70 Kofoed and Stürup reported one patient (TAR group = 14 patients) who was converted to arthrodesis for ongoing pain which persisted despite a solid fusion. 71 Soohoo et al. reported that 23% of the patients who had been treated with an arthroplasty underwent a major revision procedure by 5
years postoperatively compared with 11% of the patients who had been treated with a fusion. 77 In a retrospective observational study of STAR versus AA, Saltzman et al. concluded that, by 57 months, ankles treated with a STAR ankle replacement had better pain relief and function than ankles treated with fusion, but more postoperative complications which required surgery. 74 Similar findings were observed by Krause et al., showing a higher complication rate (54% versus 26%) in patients five years after total ankle replacement than ankle fusion. 25 Patients undergoing TAR have better function and improved gait and range of movement, including reduction of limp, and protection of other joints, compared to patients treated with an AA. 72, [87] [88] [89] [90] According to the results of this review, TAR is effective to relieve pain and restore function. Nevertheless, to ensure a successful outcome for end stage ankle OA treatment, it is important to select patients carefully. TAR and AA have advantages and disadvantages that should be considered according to patients' expectations and characteristics (e.g. bone and soft tissue quality, age, diabetes, valgus tilting, medial laxity etc.). Patients in whom ankle OA is associated with valgus tilting and medial laxity have higher risk of failure, in particular in the combination of posterior tibial tendon insufficiency and deltoid insufficiency. [91] [92] [93] [94] Higher risk for revision surgery was also reported for women younger than 60 years and for patients with poor glycaemic control. 95, 96 In contrast to TAR, ankle fusion has a significant lower cost and a better pain relief, but ankle motion is obviously lost, and gait kinematics can be affected. 72, 97 In TAR, passive range of motion was improved, all patients were affected by end stage of ankle disease and overall ROM was also improved. Gait mechanics were normalized to a greater extent following ankle arthroplasty compared with those following arthrodesis, sagittal joint motion was maintained and ankle kinematics were markedly improved compared with those undergoing arthroplasty with first-generation total ankle prostheses. 98 Assessment tools (e.g. rating scales, questionnaires) play an important role for pre-and postoperative evaluation. The studies included in this review did not report preoperative assessment in a consistent fashion. In general, all the studies reporting severity included end stage ankle OA with advanced joint destruction. Both arthroplasty and arthrodesis are indicated in patients with severe rheumatoid, post-traumatic, or primary ankle arthritis: disease severity is therefore assumed comparable between groups. To further ensure that the arthroplasty and arthrodesis groups were similar, we evaluated preoperative reports of ankle pain and function through analysis of validated outcome scores. In a recent study, the AOS-subscore for pain decreased from a baseline of 30.7 points and 29.2 points for AA and TAR respectively, to 14.5 points and 10.3 points at the time of the latest follow-up. 25 Schuh et al. evaluated retrospectively the habitual physical activity, the functional outcome and satisfaction of patients who underwent either AA or TAR for the treatment of end stage OA of the ankle joint, comparing preoperative and postoperative participation in sports and recreational activities. 63 In the arthrodesis group, 18 patients (90%) were active before operation and 15 patients (75%) were active after surgery. Three patients ceased activity after surgery. In the TAR group, preoperatively 18 patients (86%) were active in sports and 16 (76%) were active after surgery. Preoperatively, the score (UCLA) reached 4.5 points for the patients of the arthrodesis group and 4.7 points for the patients of the TAR group. For both groups the decrease was statistically significant to 3.1 points and 3.3 points, respectively, after surgery. In a more recent prospective study, Esparragozaa et al.2reported preoperative and follow-up results for each group of patients to determine whether there were significant differences between the surgical techniques. Functional outcome after TAR was satisfactory, with a statistically significant difference in AOFAS scale between preoperative values of 33 ± 4.81 points and final follow-up values of 62 ± 5.48 points (P = 0.024). In contrast, the arthrodesis group did not show a statistically significant improvement between them (P = 0.055). Outcomes of general health and quality of life through the SF-36 were statistically significant in both groups. In the arthroplasty group, the mean total value for the preoperative SF-36 was 33.62 ± 5.86. At 2 years, it was 59.84 ± 8.6, which was significantly better (P = 0.001).
Postoperative pain is a critical outcome, as it often leads to revision surgery. Most authors reported that patients undergoing arthroplasty showed better pain relief compared with patients undergoing AA. 63, 73, 74, 99 Because preservation of motion is cited as the advantage of TAR over AA, functional evaluation focused on whether patients undergoing arthroplasty had achieved a functional arc of motion. Postoperatively, TAR patients were as satisfied as patients with an AA at latest followup; these findings may be due to better postoperative function and a selection bias. Probably, the most convincing indication for TAR at this time is extensive arthritis or bilateral ankle disease in patientsaged 50-70 with good alignment and range of motion, in association with an appropriate weight and bone support. On the other hand, AA is indicated in elderly patients for severe ankle OA or combined ankle and subtalar OA that fails non operative management. 78, 79, [98] [99] [100] When counseling patients who are considering their options with regard to ankle arthritis treatment, it is up to the surgeon to determine which procedure is likely to give the best results for their patient on an individual basis.
Ultimately, longer follow-up on patients receiving TAR, and randomized controlled studies are necessary to guide future indications for treatment of ankle OA.
Limitations
This study has some limitations. First, a proper analysis of comorbidities (diabetes, rheumatoid arthritis etc.) was not performed, as the included studies did not report sufficient data for statistical analysis; the severity of complications (e.g. infection), was also not described. Further, no librarian or statistician were involved in this study.
Conclusions
Although there is some evidence to support TAR for conserving ankle motion and offering improved function and decreased pain with high satisfaction rates, revision rates for TAR is significant higher than revision rate for AA. Furthermore, concerns have been raised over the potential long-term risk of arthritis in the surrounding joints of the foot (talonavicular, calcaneocuboid, and/or subtalar joint) after AA. When considering other treatment options, TAR is an attractive alternative given the theoretical benefit of motion preservation. However, because of the paucity of long-term data, there is insufficient evidence to recommend total ankle replacement over arthrodesis for all patients at this time. 100 Proper patient selection is critical for successful treatment of end-stage ankle OA.
The findings of this study should promote effective planning for future multicenter clinical trials comparing outcomes for TAR and AA.
